Back to School: How biopharma can reboot drug development. Access exclusive analysis here

By the Numbers; Who HASN'T raised money

By the Numbers; Who HASN'T raised money

Mtk cap group Total# cos # cos raising $ $ raised % of total $
>$3B 31 13 3,706M 43%
$1B-$3B 40 23 3,016M 35%
$700M-$1B 26 8 431M 5%
$300M-$700M 72 27 1,079M 12%
$100M-$300M 96 32 380M

Read the full 465 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE